Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-03-23 Sale |
2021-03-25 5:39 pm |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
100,000 | $128.05 | $12,805,240 | 122,716 (Direct) |
View |
2021-03-22 Sale |
2021-03-24 6:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,374 | $132.37 | $4,020,667 | 1,585,335 (Indirect Direct) |
View |
2021-02-19 Sale |
2021-02-23 4:40 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
171,003 | $149.11 | $25,497,840 | 1,628,724 (Indirect Direct) |
View |
2021-01-15 Sale |
2021-01-20 6:11 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $213.67 | $4,273,311 | 291,972 (Direct) |
View |
2021-01-15 Sale |
2021-01-20 6:07 pm |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
25,000 | $215.2 | $5,379,940 | 34,666 (Direct) |
View |
2021-01-19 Sale |
2021-01-20 6:05 pm |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
27,500 | $204.94 | $5,635,944 | 34,931 (Direct) |
View |
2020-12-21 Sale |
2020-12-22 4:55 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
23,551 | $149.23 | $3,514,610 | 270,413 (Direct) |
View |
2020-12-16 Sale |
2020-12-18 7:12 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $148.95 | $2,234,266 | 3,040,462 (Indirect Direct) |
View |
2020-12-10 Sale(A) |
2020-12-17 7:14 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) |
View |
2020-12-10 Sale |
2020-12-14 7:11 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
33,000 | $143.35 | $4,730,448 | 3,055,462 (Indirect Direct) |
View |
2020-12-10 Sale |
2020-12-11 4:05 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $142.29 | $2,845,782 | 311,972 (Direct) |
View |
2020-12-07 Sale |
2020-12-09 7:54 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
171,004 | $154.53 | $26,424,505 | 3,088,462 (Indirect Direct) |
View |
2020-11-30 Sale |
2020-12-02 4:26 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
100,000 | $125 | $12,500,000 | 850,215 (Direct) |
View |
2020-10-08 Sale |
2020-10-13 4:44 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $100 | $2,500,000 | 1,031,399 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-10 Option Award |
2021-06-14 6:23 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:39 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:39 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | High Katherine A Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:38 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Greene John Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:37 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | George Simeon Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:36 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
10,000 | $0 | 10,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 5:35 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Fleming Harold Edward Director |
25,000 | $0 | 25,000 (Direct) |
View |
2021-06-01 Tax Withholding |
2021-06-03 5:34 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $115.8 | 187,719 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,000 | $17.66 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A 2027-06-14 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
88,000 | $0 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,000 | $44.67 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
22,000 | $51.49 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
10,000 | $29.87 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
12,000 | $14.43 | 122,716 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 5:39 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
20,000 | $40.87 | 122,716 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
1,352 | $124.15 | 36,251 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
2,833 | $0 | 36,251 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:50 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
34,360 | $0 | 36,251 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,526 | $124.15 | 324,498 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
11,833 | $0 | 324,498 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:49 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
136,000 | $0 | 324,498 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
2,141 | $124.15 | 58,384 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:47 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
4,583 | $0 | 58,384 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:47 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
45,334 | $0 | 58,384 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
1,353 | $124.15 | 58,271 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:43 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
2,833 | $0 | 58,271 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:43 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
34,360 | $0 | 58,271 (Direct) |
View |
2021-03-10 Tax Withholding |
2021-03-12 5:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
2,141 | $124.15 | 70,638 (Direct) |
View |
2021-03-10 Exercise |
2021-03-12 5:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
4,583 | $0 | 70,638 (Direct) |
View |
2021-03-11 Option Award |
2021-03-12 5:41 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
32,334 | $0 | 70,638 (Direct) |
View |
2021-01-15 Exercise(A) |
2021-03-12 5:37 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
16,334 | $14.43 | 37,550 (Direct) |
View |
2021-03-05 Exercise |
2021-03-09 5:40 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
3,333 | $0 | 35,862 (Direct) |
View |
2021-03-05 Tax Withholding |
2021-03-09 5:40 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
1,585 | $114.65 | 35,862 (Direct) |
View |
2021-03-01 Other |
2021-03-03 4:23 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
407,434 | $0 | 1,365,779 (Indirect) |
View |
2021-03-01 Tax Withholding |
2021-03-03 4:13 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
798 | $130.25 | 182,191 (Direct) |
View |
2021-02-19 Other |
2021-02-23 4:40 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,416,648 | $0 | 1,628,724 (Indirect) |
View |
2021-01-15 Exercise |
2021-01-20 6:11 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $1.81 | 291,972 (Direct) |
View |
2021-01-15 Exercise |
2021-01-20 6:11 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 291,972 (Direct) |
View |
2021-01-15 Exercise |
2021-01-20 6:07 pm |
N/A 2026-07-14 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
25,000 | $0 | 34,666 (Direct) |
View |
2021-01-15 Exercise |
2021-01-20 6:07 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
16,344 | $14.43 | 34,666 (Direct) |
View |
2021-01-15 Exercise |
2021-01-20 6:07 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
8,666 | $12.57 | 34,666 (Direct) |
View |
2021-01-19 Exercise |
2021-01-20 6:05 pm |
N/A 2028-03-07 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
27,500 | $0 | 34,931 (Direct) |
View |
2021-01-19 Exercise |
2021-01-20 6:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
27,500 | $51.49 | 34,931 (Direct) |
View |
2021-01-02 Tax Withholding |
2021-01-04 4:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
9,392 | $153.11 | 10,608 (Direct) |
View |
2020-12-29 Exercise |
2020-12-30 4:02 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,800 | $1.81 | 311,972 (Direct) |
View |
2020-12-29 Exercise |
2020-12-30 4:02 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,800 | $0 | 311,972 (Direct) |
View |
2020-12-21 Exercise |
2020-12-22 4:55 pm |
N/A 2027-08-01 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
23,551 | $0 | 270,413 (Direct) |
View |
2020-12-21 Exercise |
2020-12-22 4:55 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
23,551 | $16.9 | 270,413 (Direct) |
View |
2020-12-10 Exercise |
2020-12-11 4:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $1.81 | 311,972 (Direct) |
View |
2020-12-10 Exercise |
2020-12-11 4:05 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 311,972 (Direct) |
View |
2020-12-09 Exercise |
2020-12-10 4:35 pm |
N/A 2027-05-31 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
22,026 | $0 | 123,389 (Direct) |
View |
2020-12-09 Exercise |
2020-12-10 4:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
22,026 | $13.62 | 123,389 (Direct) |
View |
2020-12-01 Tax Withholding |
2020-12-03 4:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $129.58 | 169,189 (Direct) |
View |
2020-11-30 Exercise |
2020-12-02 4:26 pm |
N/A 2026-10-18 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
100,000 | $0 | 850,215 (Direct) |
View |
2020-11-30 Exercise |
2020-12-02 4:26 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $14 | 850,215 (Direct) |
View |
2020-11-30 Exercise |
2020-12-02 4:26 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $14.43 | 850,215 (Direct) |
View |
2020-10-29 Other |
2020-11-02 5:30 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
536,996 | $0 | 2,566,055 (Indirect) |
View |
2020-10-08 Exercise |
2020-10-13 4:44 pm |
N/A 2027-06-15 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $0 | 1,031,399 (Direct) |
View |
2020-10-08 Exercise |
2020-10-13 4:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $14.43 | 1,031,399 (Direct) |
View |
2020-10-05 Option Award |
2020-10-06 5:48 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
11,666 | $0 | 11,666 (Direct) |
View |
2020-10-05 Option Award |
2020-10-06 5:45 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
47,333 | $0 | 47,333 (Direct) |
View |
2020-10-05 Option Award |
2020-10-06 5:38 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
16,666 | $0 | 16,666 (Direct) |
View |